首页 > 市场调查报告书 > 医疗设备

e保健医院 IT

市场调查报告书

商品编码

1345376

全球电子处方市场 - 2023-2030

Global E-prescribing Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球电子处方市场将于 2022 年达到 29 亿美元，预计到 2030 年将达到 94 亿美元，2023-2030 年预测期间复合年增长率为 16.4%。

电子处方是利用医疗保健技术来提高处方准确性、提高患者安全性和降低成本，同时还能在临床医生和药剂师之间实现安全、实时、双向的电子连接。用药错误和药物不良事件每年导致约 7,500 人死亡，每年与药物相关的发病率和死亡率造成的损失估计高达 750 亿美元。

此外，电子病历解决方案、政府倡议和激励计划的日益采用、对减少欺诈、受控物质/药物滥用的日益关注以及医疗保健提供者越来越多地采用电子处方等因素正在推动电子处方的增长。 -规定市场规模。由于美国和加拿大等国家技术进步的巨大进步，北美地区的市场需求不断增加。

动力学

公司遵循的策略有助于推动市场增长

公司遵循的产品发布、合作和其他策略有助于推动该细分市场的增长。例如，2022 年8 月18 日，具有前瞻性思维的生物技术公司Parker Health 宣布与FDB Vela 合作，FDB Vela 是一个新的云原生电子处方(ePrescribing) 网络，可实现关键药物处方信息、福利的无缝流动。处方者、付款人、药房和其他各方之间的验证和临床决策支持。

借助 FDB Vela 的完整 API 经验，Parker Health 可以定制 Parker Suite Health Management System 在网络和移动应用程序中为处方者显示处方信息的方式。

此外，2023 年3 月，DoseSpot（一个允许临床医生以电子方式编写处方并将处方传输到药房的SaaS 平台）收购了Bravado Health 的TreatRx 部门，以加强和扩展DoseSpot 为医疗保健提供商提供的解决方案集，并帮助提升其在电子处方软件中的地位整合市场。因此，这些组织的倡议有助于推动市场扩张。

不断增长的老年人口和政府的努力正在推动市场增长

根据 AHIMA 健康信息管理展望中发表的一项研究，电子处方对于老年患者来说既是一种预期也是首选的技术，因为他们中的大多数人每天必须兼顾多种药物。患者认为电子处方比纸质处方更安全、更方便、更高效，并且它促进了与医疗保健从业者的更多沟通，这可能有助于提高用药安全性。

例如，根据世界卫生组织的数据，到 2030 年，世界上大约五分之一的人将年龄在 60 岁或以上。此时60岁及以上人口的比例将从2020年的10亿增加到14亿。到 2050 年，世界 60 岁及以上人口数量将增加一倍。 2020 年至 2050 年间，80 岁及以上的人口数量预计将增加两倍，达到 4250 亿。因此，上述因素有助于推动市场增长。

软件设计问题将阻碍市场增长

电子处方软件的设计元素可能会增加出错的可能性。例如，下拉菜单、糟糕的屏幕设计和自动填充功能已被认为是错误的潜在原因，从而对患者安全构成威胁。此外，由于他们需要人工记录和更新处方，以及与提供者进行潜在的后续行动以弥补差距、不准确或缺乏清晰度，这些设计方面可能会导致工作流程问题。

患者的不满和更长的等待时间可能是由于新电子处方到达的延迟造成的，因为患者可能会在收到订单之前到达药房。因此，上述因素限制了市场的拓展。

有关此报告的更多详细信息 - 索取样品

Market Overview

Global E-prescribing Market reached US$ 2.9 billion in 2022 and is expected to reach US 9.4 billion by 2030 growing with a CAGR of 16.4% during the forecast period 2023-2030.

E-prescribing is the use of health care technology to improve prescription accuracy, boost patient safety, and lower costs while also enabling secure, real-time, bidirectional electronic connectivity between clinicians and pharmacists. Medication errors and adverse drug events cause roughly 7,500 fatalities each year, with an estimated annual cost of drug-related morbidity and mortality reaching $75 billion.

Additionally, factors such as the rising adoption of EHR solutions, government initiatives, and incentive programs, the rising focus on reducing fraud, controlled substances/drug abuse, and the increasing adoption of e-prescriptions by healthcare providers are driving the growth of the e-prescribing market size. Due to the massive rise in technological advancements in countries like the U.S. and Canada, the market is experincing an rise in demand from North American regions.

Dynamics

The Strategies Followed by the Companies Helps to Drive the Market Growth

The product launches, collabrations and other strategies followed by the companies helps to drive the segment growth. For instance, on August 18, 2022, Parker Health, a forward-thinking biotechnology company, has announced a collaboration with FDB Vela, a new cloud-native electronic prescribing (ePrescribing) network that enables the seamless flow of critical medication prescription information, benefits verification, and clinical decision support between prescribers, payers, pharmacies, and other constituents.

Parker Health can customise how the Parker Suite Health Management System presents prescription information inside the web and mobile applications for prescribers thanks to FDB Vela's full API experience.

Additionally, in March 2023, DoseSpot, a SaaS platform that allows clinicians to electronically write and transmit prescriptions to pharmacies, has acquired the TreatRx segment of Bravado Health to strengthen and expand DoseSpot's solution set for healthcare providers and help advance its position in the ePrescribing software integration market. Thus, the organisations' initiatives aid in driving market expansion.

Growing Geriatric Population and Government Efforts are Pushing the Market Growth

According to a study published in AHIMA's Perspectives in Health Information Management, electronic prescribing is both an expected and preferred technology for elderly patients, the majority of whom must juggle many drugs on a daily basis. Patients perceive ePrescribing to be safer, more convenient, and more efficient than paper-based prescriptions, and it fosters increased communication with healthcare practitioners, which may contribute to enhanced medication safety.

For instance, according to WHO, by 2030, around 1 in 5 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1.0 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 425 Billion. Thus above factors helps to drive the market growth.

The Software Design Issues will Hamper the Market Growth

E-prescribing software's design elements may enhance the chance of errors. Drop-down menus, bad screen design, and automatic filling functions, for example, have been noted as potential causes of errors and, as a result, hazards to patient safety. Furthermore, because they need human recording and updating of prescriptions, as well as potential follow-up with providers to remedy gaps, inaccuracies, or lack of clarity, these design aspects may contribute to workflow issues.

Patient dissatisfaction and longer waiting times might come from delays in the arrival of new e-prescriptions, as patients may arrive at the pharmacy before an order has been received. As a result, the above factors restrict market expansion.

For more details on this report - Request for Sample

Segment Analysis

The global E-prescribing market is segmented based on system type, delivery mode, component, end user and region.

The Software Accounted for Approximately 51.7% of the E-prescribing Market Share

Software has grown essential in the healthcare industry. Initially, software was viewed as only a means of digitising a patient's medical document and record. Since then, software has evolved to manage the exponential increase in the amount of data required by modern healthcare practitioners.

E-prescribing has been implemented as a fundamental feature by manufacturers in an effort to increase functionality and attract healthcare systems to use their platforms. This is advantageous because, even if new patients visit a medical practise for the first time, their digital healthcare record may be safely followed. Technological developments contribute to the segment's growth.

For instance, Kareo is one of the most popular software alternatives for healthcare organisations without an EMR system in 2021. According to the Kareo review, the programme is accessible from any device and provides clinicians with various useful options, such as saving frequently prescribed medications as favourites. Other top performers provide e-prescribing software that may be used as a standalone application or that connects with existing EHR platforms. As a result, the aforementioned elements contribute to segment growth.

Geographical Penetration

North America Accounted for Approximately 45.4% of the Market Share in 2022

North America is predicted to be the fastest growing regional market share owing to the increasing adoption of electronic prescribing systems and initiatives encouraging e-prescribing, such as the National Council for Prescription Drugs Program and the Health Information Technology for Economic and Clinical Health (HITECH) Act.

Moreover, the advanced regional healthcare infrastructure, and the presence of established market players such as Surescripts-Rxhub LLC, NextGen Healthcare, Oracle, Epic Systems Corporation, NextGen Healthcare, Inc., and Athenahealth, Inc and rise in healthcare expenditure will helps to drive the region growth .

For instance, according to the National Health Expenditure Account (NHEA), the total annual healthcare expenditure in the United States is increased by 2.7% to $4.3 trillion. Physician spending grew by an average of 3.8% per year while hospital services (4.5%) and clinical services (6.6%) had higher growth rates.

Competitive Landscape

The major global players in the E-prescribing market CharmHealth, Cerner Corporation, GE Healthcare, Epic Systems Corporation, ScriptSure, Athenahealth, iCare Billing, NextGen Healthcare, DrFirst, Inc, RelayHealth, LLC and others.

COVID-19 Impact Analysis

The positive market impact of e-prescribe, which has been widely implemented throughout the world, is the inefficiency of written prescriptions. In a rush, doctors can write trivial mistakes, and chemists may struggle to read the doctor's writing. As a result, the patient is kept at the pharmacy for longer than necessary due to the lengthy decoding procedure. It can also form lines, increasing visitor contact.

E-prescribing has the potential to increase patient access to prescription drugs while also being convenient. The surge in e-prescribing during the lockout revealed how the system may be improved, including better mistake feedback, greater uniformity between practises and pharmacies, more proactive engagement with patients, and more equitable prescribing prices.

By System Type

Integrated System
Standalone System

By Delivery Mode

Web/Cloud-based
On-premise

By Component

Software
Hardware
Services

By End User

Hospitals and Clinics
Office-based Physicians
Pharmacy

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In August 2022, CLEO Systems has launched an electronic prescription system with the goal of reducing prescribing errors, increasing sustainability, and simplifying the process for both professionals and patients. CLEO SOLO EPS provides practitioners with immediate prescribing capabilities, eliminating the requirement for system integration. This means that once a patient's prescription is entered, it can be electronically transmitted to a designated community pharmacy.
On October 11, 2022, Walgreens Boots Alliance, Inc. stated that it has accelerated its intentions to acquire full ownership of CareCentrix, expanding its reach into the booming homecare sector and pursuing its long-term healthcare growth strategy. WBA has entered into a permanent agreement to acquire the remaining 45% ownership in CareCentrix for approximately $392 Billion, based on the exit multiple agreed to when WBA announced its first majority investment in CareCentrix.
On August 01, 2023, The Central and North West London NHS Foundation Trust's addictions service (CNWL Addictions) has announced the introduction of their EPS. It claims to be the country's first addictions service to introduce an EPS, which means patients will no longer have to wait at the unit for their paper prescriptions to be prepared.

Why Purchase the Report?

To visualize the global E-prescribing market segmentation based on system type, delivery mode, component, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of E-prescribing market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global E-prescribing market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by System Type
3.2. Snippet by Delivery Mode
3.3. Snippet by Component
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The strategies followed by the companies
  - 4.1.1.2. Growing geriatric population and Government efforts
- 4.1.2. Restraints
  - 4.1.2.1. The software design issues
- 4.1.3. Opportunity
  - 4.1.3.1. Additional research and development of new technologies
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By System Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By System Type
- 7.1.2. Market Attractiveness Index, By System Type
7.2. Integrated System *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.2.3. Standalone System

8. By Delivery Mode

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
- 8.1.2. Market Attractiveness Index, By Delivery Mode
8.2. Web/Cloud-based *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. On-premise

9. By Component

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 9.1.2. Market Attractiveness Index, By Component
9.2. Software*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hardware
9.4. Services

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Office-based Physicians
10.4. Pharmacy

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. U.K.
  - 11.3.7.3. France
  - 11.3.7.4. Spain
  - 11.3.7.5. Italy
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By System Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. CharmHealth*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Cerner Corporation
13.3. GE Healthcare
13.4. Epic Systems Corporation
13.5. ScriptSure
13.6. Athenahealth
13.7. iCare Billing
13.8. NextGen Healthcare
13.9. DrFirst, Inc
13.10. RelayHealth, LLC.

LIST NOT EXHAUSTIVE